One platform for all researcher needs
AI-powered academic writing assistant
Your #1 AI companion for literature search
AI tool for graphics, illustrations, and artwork
Unlock unlimited use of all AI tools with the Editage All Access membership.
Explore Editage All Access
Search from 250 M+ research papersSearch from 250 M+ research papers
Open Accesshttps://doi.org/10.1182/blood-2020-136566
Copy DOI Journal: Blood |  Publication Date: Nov 5, 2020 |
 Citations: 3 |
Affiliation: BerGenBio (Norway), University of Bergen, Universität Hamburg, University Medical Center Hamburg-Eppendorf, University Cancer Center Hamburg, The University of Texas MD Anderson Cancer Center, German Cancer Research Center, Heidelberg University, University of Parma, Haukeland University Hospital, University of Genoa, Hannover Medical School, Vanderbilt University, University Hospital Ulm, University Hospital Frankfurt, Goethe University Frankfurt, Ospedale Vito Fazzi, Azienda Sanitaria Ospedaliera S.Croce e Carle CuneoThe Combination of AXL Inhibitor Bemcentinib and Low Dose Cytarabine Is Well Tolerated and Efficacious in Elderly Relapsed AML Patients: Update from the Ongoing BGBC003 Phase II Trial (NCT02488408)
Sign-in/Register to access full text options 
Free) Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
